Skip to main content
Erschienen in: Herzschrittmachertherapie + Elektrophysiologie 3/2015

01.09.2015 | Original Contribution

Adjunctive surgical atrial fibrillation ablation during cardiac surgery: real life experiences

verfasst von: T.S. Tischer, R. Schneider, J. Lauschke, C. Nesselmann, G. Steinhoff, Dietmar Bänsch, MD

Erschienen in: Herzschrittmachertherapie + Elektrophysiologie | Ausgabe 3/2015

Einloggen, um Zugang zu erhalten

Abstract

Aim

Several tools have been invented for surgical atrial fibrillation (AF) ablation. In this study, we investigated the real world efficacy of intraoperative AF ablation (AFA) with radiofrequency-energy or cryo-ablation and performed an electro-anatomical remap in some patients with recurrences.

Methods

Seventy-three consecutive patients (53 male, median age of 69 ± 7 years) with history of AF underwent cardiac surgery for valve repair (74 % mitral defects, 60 % aortic defects) and/or coronary artery bypass graft procedures (56 %). During a follow-up of 23 ± 11 months after AFA we performed intensified holter-monitoring (4–7 days). Patients with symptomatic relapse of atrial arrhythmias (AA) were offered the opportunity for additional electrophysiological examination (EPE).

Results

During 23 ± 11 months after AFA, 45 patients (62 %) had recurrent AA. In eight patients we performed EPE. In all 8 cases, septal circumferential lesions could be demonstrated during mapping with discrete gaps. All lateral veins were isolated however, posteriorly deep inside the vein leaving the antral region completely untreated. Neither roof lines nor mitral isthmus lines were complete. Performing catheter ablation, all veins could be isolated and seven patients were free of any arrhythmias during follow up (9 ± 5 months) without taking antiarrhythmic drugs.

Conclusion

Surgical AF ablation may often be incomplete rendering sobering results in unselected patients. Completion of the ablation is feasible with catheter ablation with good clinical outcome.
Literatur
1.
Zurück zum Zitat Fuster V, Ryden LE, Cannom DS, Crijns HJ, Curtis AB, Ellenbogen KA et al (2006) ACC/AHA/ESC 2006 Guidelines for the Management of Patients with Atrial Fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation): developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society. Circulation 114:e257–e354CrossRefPubMed Fuster V, Ryden LE, Cannom DS, Crijns HJ, Curtis AB, Ellenbogen KA et al (2006) ACC/AHA/ESC 2006 Guidelines for the Management of Patients with Atrial Fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation): developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society. Circulation 114:e257–e354CrossRefPubMed
2.
Zurück zum Zitat Santangeli P, Di Biase L, Natale A (2014) Ablation versus drugs: what is the best first-line therapy for paroxysmal atrial fibrillation? Antiarrhythmic drugs are outmoded and catheter ablation should be the first-line option for all patients with paroxysmal atrial fibrillation: pro. Circ Arrhythm Electrophysiol 7:739–746CrossRefPubMed Santangeli P, Di Biase L, Natale A (2014) Ablation versus drugs: what is the best first-line therapy for paroxysmal atrial fibrillation? Antiarrhythmic drugs are outmoded and catheter ablation should be the first-line option for all patients with paroxysmal atrial fibrillation: pro. Circ Arrhythm Electrophysiol 7:739–746CrossRefPubMed
4.
Zurück zum Zitat Harada A, Sasaki K, Fukushima T, Ikeshita M, Asano T, Yamauchi S et al (1996) Atrial activation during chronic atrial fibrillation in patients with isolated mitral valve disease. Ann Thorac Surg 61:104–111. (discussion 11–12)CrossRefPubMed Harada A, Sasaki K, Fukushima T, Ikeshita M, Asano T, Yamauchi S et al (1996) Atrial activation during chronic atrial fibrillation in patients with isolated mitral valve disease. Ann Thorac Surg 61:104–111. (discussion 11–12)CrossRefPubMed
5.
Zurück zum Zitat Romero I, Nedios S, Kriatselis C (2014) Diagnosis and management of atrial fibrillation: an overview. Cardiovasc Ther 32:242–252CrossRefPubMed Romero I, Nedios S, Kriatselis C (2014) Diagnosis and management of atrial fibrillation: an overview. Cardiovasc Ther 32:242–252CrossRefPubMed
6.
Zurück zum Zitat Cox JL, Schuessler RB, D’Agostino HJ Jr, Stone CM, Chang BC, Cain ME et al (1991) The surgical treatment of atrial fibrillation. III. Development of a definitive surgical procedure. J Thorac Cardiovasc Surg 101:569–583PubMed Cox JL, Schuessler RB, D’Agostino HJ Jr, Stone CM, Chang BC, Cain ME et al (1991) The surgical treatment of atrial fibrillation. III. Development of a definitive surgical procedure. J Thorac Cardiovasc Surg 101:569–583PubMed
7.
Zurück zum Zitat Calkins H, Kuck KH, Cappato R, Brugada J, Camm AJ, Chen SA et al (2012) HRS/EHRA/ECAS expert consensus statement on catheter and surgical ablation of atrial fibrillation: recommendations for patient selection, procedural techniques, patient management and follow-up, definitions, endpoints, and research trial design: a report of the Heart Rhythm Society (HRS) Task Force on Catheter and Surgical Ablation of Atrial Fibrillation. Developed in partnership with the European Heart Rhythm Association (EHRA), a registered branch of the European Society of Cardiology (ESC) and the European Cardiac Arrhythmia Society (ECAS); and in collaboration with the American College of Cardiology (ACC), American Heart Association (AHA), the Asia Pacific Heart Rhythm Society (APHRS), and the Society of Thoracic Surgeons (STS). Endorsed by the governing bodies of the American College of Cardiology Foundation, the American Heart Association, the European Cardiac Arrhythmia Society, the European Heart Rhythm Association, the Society of Thoracic Surgeons, the Asia Pacific Heart Rhythm Society, and the Heart Rhythm Society. Heart Rhythm 9:632–696.e21CrossRefPubMed Calkins H, Kuck KH, Cappato R, Brugada J, Camm AJ, Chen SA et al (2012) HRS/EHRA/ECAS expert consensus statement on catheter and surgical ablation of atrial fibrillation: recommendations for patient selection, procedural techniques, patient management and follow-up, definitions, endpoints, and research trial design: a report of the Heart Rhythm Society (HRS) Task Force on Catheter and Surgical Ablation of Atrial Fibrillation. Developed in partnership with the European Heart Rhythm Association (EHRA), a registered branch of the European Society of Cardiology (ESC) and the European Cardiac Arrhythmia Society (ECAS); and in collaboration with the American College of Cardiology (ACC), American Heart Association (AHA), the Asia Pacific Heart Rhythm Society (APHRS), and the Society of Thoracic Surgeons (STS). Endorsed by the governing bodies of the American College of Cardiology Foundation, the American Heart Association, the European Cardiac Arrhythmia Society, the European Heart Rhythm Association, the Society of Thoracic Surgeons, the Asia Pacific Heart Rhythm Society, and the Heart Rhythm Society. Heart Rhythm 9:632–696.e21CrossRefPubMed
8.
Zurück zum Zitat Melby SJ, Zierer A, Bailey MS, Cox JL, Lawton JS, Munfakh N et al (2006) A new era in the surgical treatment of atrial fibrillation: the impact of ablation technology and lesion set on procedural efficacy. Ann Surg 244:583–592PubMedCentralPubMed Melby SJ, Zierer A, Bailey MS, Cox JL, Lawton JS, Munfakh N et al (2006) A new era in the surgical treatment of atrial fibrillation: the impact of ablation technology and lesion set on procedural efficacy. Ann Surg 244:583–592PubMedCentralPubMed
9.
Zurück zum Zitat Chiappini B, Martin-Suarez S, LoForte A, Arpesella G, Di Bartolomeo R, Marinelli G (2004) Cox/Maze III operation versus radiofrequency ablation for the surgical treatment of atrial fibrillation: a comparative study. Ann Thorac Surg 77:87–92CrossRefPubMed Chiappini B, Martin-Suarez S, LoForte A, Arpesella G, Di Bartolomeo R, Marinelli G (2004) Cox/Maze III operation versus radiofrequency ablation for the surgical treatment of atrial fibrillation: a comparative study. Ann Thorac Surg 77:87–92CrossRefPubMed
10.
Zurück zum Zitat Ouyang F, Bansch D, Ernst S, Schaumann A, Hachiya H, Chen M et al (2004) Complete isolation of left atrium surrounding the pulmonary veins: new insights from the double-Lasso technique in paroxysmal atrial fibrillation. Circulation 110:2090–2096CrossRefPubMed Ouyang F, Bansch D, Ernst S, Schaumann A, Hachiya H, Chen M et al (2004) Complete isolation of left atrium surrounding the pulmonary veins: new insights from the double-Lasso technique in paroxysmal atrial fibrillation. Circulation 110:2090–2096CrossRefPubMed
11.
Zurück zum Zitat Ernst S, Broemel T, Krumsdorf U, Hachiya H, Ouyang F, Linder C et al (2003) [Three-dimensional reconstruction of pulmonary veins and left atrium. Implications for catheter ablation of atrial fibrillation]. Herz 28:559–565CrossRefPubMed Ernst S, Broemel T, Krumsdorf U, Hachiya H, Ouyang F, Linder C et al (2003) [Three-dimensional reconstruction of pulmonary veins and left atrium. Implications for catheter ablation of atrial fibrillation]. Herz 28:559–565CrossRefPubMed
12.
Zurück zum Zitat Maltais S, Forcillo J, Bouchard D, Carrier M, Cartier R, Demers P et al (2010) Long-term results following concomitant radiofrequency modified maze ablation for atrial fibrillation. J Card Surg 25:608–613CrossRefPubMed Maltais S, Forcillo J, Bouchard D, Carrier M, Cartier R, Demers P et al (2010) Long-term results following concomitant radiofrequency modified maze ablation for atrial fibrillation. J Card Surg 25:608–613CrossRefPubMed
13.
Zurück zum Zitat Geidel S, Krause K, Boczor S, Kuck KH, Lass M, Ostermeyer J et al (2011) Ablation surgery in patients with persistent atrial fibrillation: an 8-year clinical experience. J Thorac Cardiovasc Surg 141:377–382CrossRefPubMed Geidel S, Krause K, Boczor S, Kuck KH, Lass M, Ostermeyer J et al (2011) Ablation surgery in patients with persistent atrial fibrillation: an 8-year clinical experience. J Thorac Cardiovasc Surg 141:377–382CrossRefPubMed
14.
Zurück zum Zitat Geidel S, Lass M, Krause K, Schneider C, Boczor S, Kuck KH et al (2011) Persistent atrial fibrillation ablation concomitant to coronary surgery. Thorac Cardiovasc Surg 59:207–212CrossRefPubMed Geidel S, Lass M, Krause K, Schneider C, Boczor S, Kuck KH et al (2011) Persistent atrial fibrillation ablation concomitant to coronary surgery. Thorac Cardiovasc Surg 59:207–212CrossRefPubMed
15.
Zurück zum Zitat Iwamura T, Kajimoto K, Yamamoto T, Yamasaki M, Tambara K, Yoneda Y et al (2011) Mid-term results for the Maze procedure in patients with non-mitral valvular atrial fibrillation. Ann Thorac Cardiovasc Surg 17:356–362CrossRefPubMed Iwamura T, Kajimoto K, Yamamoto T, Yamasaki M, Tambara K, Yoneda Y et al (2011) Mid-term results for the Maze procedure in patients with non-mitral valvular atrial fibrillation. Ann Thorac Cardiovasc Surg 17:356–362CrossRefPubMed
16.
Zurück zum Zitat Wang J, Li Y, Shi J, Han J, Xu C, Ma C et al (2011) Minimally invasive surgical versus catheter ablation for the long-lasting persistent atrial fibrillation. PloS One 6:e22122CrossRefPubMedCentralPubMed Wang J, Li Y, Shi J, Han J, Xu C, Ma C et al (2011) Minimally invasive surgical versus catheter ablation for the long-lasting persistent atrial fibrillation. PloS One 6:e22122CrossRefPubMedCentralPubMed
17.
Zurück zum Zitat Wang JG, Li Y, Shi JH, Han J, Cui YQ, Luo TG et al (2011) Treatment of long-lasting persistent atrial fibrillation using minimally invasive surgery combined with irbesartan. Ann Thorac Surg 91:1183–1189CrossRefPubMed Wang JG, Li Y, Shi JH, Han J, Cui YQ, Luo TG et al (2011) Treatment of long-lasting persistent atrial fibrillation using minimally invasive surgery combined with irbesartan. Ann Thorac Surg 91:1183–1189CrossRefPubMed
18.
Zurück zum Zitat Pires LM, Leiria TL, de Lima GG, Kruse ML, Nesralla IA, Kalil RA (2010) Comparison of surgical cut and sew versus radiofrequency pulmonary veins isolation for chronic permanent atrial fibrillation: a randomized study. Pacing Clin Electrophysiol 33:1249–1257CrossRefPubMed Pires LM, Leiria TL, de Lima GG, Kruse ML, Nesralla IA, Kalil RA (2010) Comparison of surgical cut and sew versus radiofrequency pulmonary veins isolation for chronic permanent atrial fibrillation: a randomized study. Pacing Clin Electrophysiol 33:1249–1257CrossRefPubMed
Metadaten
Titel
Adjunctive surgical atrial fibrillation ablation during cardiac surgery: real life experiences
verfasst von
T.S. Tischer
R. Schneider
J. Lauschke
C. Nesselmann
G. Steinhoff
Dietmar Bänsch, MD
Publikationsdatum
01.09.2015
Verlag
Springer Berlin Heidelberg
Erschienen in
Herzschrittmachertherapie + Elektrophysiologie / Ausgabe 3/2015
Print ISSN: 0938-7412
Elektronische ISSN: 1435-1544
DOI
https://doi.org/10.1007/s00399-015-0379-1

Weitere Artikel der Ausgabe 3/2015

Herzschrittmachertherapie + Elektrophysiologie 3/2015 Zur Ausgabe

Screening-Mammografie offenbart erhöhtes Herz-Kreislauf-Risiko

26.04.2024 Mammografie Nachrichten

Routinemäßige Mammografien helfen, Brustkrebs frühzeitig zu erkennen. Anhand der Röntgenuntersuchung lassen sich aber auch kardiovaskuläre Risikopatientinnen identifizieren. Als zuverlässiger Anhaltspunkt gilt die Verkalkung der Brustarterien.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

25.04.2024 Hypertonie Nachrichten

Beginnen ältere Männer im Pflegeheim eine Antihypertensiva-Therapie, dann ist die Frakturrate in den folgenden 30 Tagen mehr als verdoppelt. Besonders häufig stürzen Demenzkranke und Männer, die erstmals Blutdrucksenker nehmen. Dafür spricht eine Analyse unter US-Veteranen.

Adipositas-Medikament auch gegen Schlafapnoe wirksam

24.04.2024 Adipositas Nachrichten

Der als Antidiabetikum sowie zum Gewichtsmanagement zugelassene Wirkstoff Tirzepatid hat in Studien bei adipösen Patienten auch schlafbezogene Atmungsstörungen deutlich reduziert, informiert der Hersteller in einer Vorab-Meldung zum Studienausgang.

Update Kardiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.